“I believe that having global public–private partnerships from the very beginning has been a key factor in the GHIT Fund’s success to date.”

Hon. Prof. Keizo Takemi

Member of the House of Councillors of Japan
Chairman, Special Committee on Global Health Strategy
of the Liberal Democratic Party's Policy

STAKEHOLDER INTERVIEWS

“Through GHIT, I believe Japan strengthened its commitment to eradicate, eliminate and control of NTDs for the common goal of a healthier world.”

Dr. Aya Yajima

Technical Officer
Malaria, other Vectorborne and Parasitic Diseases Unit
Division of Communicable Diseases
World Health Organization Western Pacific Regional Office

STAKEHOLDER INTERVIEWS

“GHIT is definitely one of these strategic investments; it delivers an enormous return.”

Prof. Stephen Caddick

Director, Innovations Division,
Wellcome Trus

STAKEHOLDER INTERVIEWS
 

NEWSJourney with us through GHIT’s Past and Future

  • 2017.08.10 NEWS New interview articles have been released
  • 2017.07.13 NEWS New interview articles have been released
  • 2017.06.05 NEWS GHIT Fund 5th Anniversary Film Released
  • 2017.06.01 NEWS New content "GHIT FUTURE" has been added
  • 2017.06.01 NEWS New interview articles have been released
  • 2017.05.10 NEWS New interview articles have been released
  • 2017.04.10 NEW SITE OPEN NEW GHIT Fund 5th Anniversary Website Launched

GHIT FUND HISTORYOur first 5 years (2013-2017)

GHIT FUND FUTUREPlans for the next 5 years (2018-2022)

STAKEHOLDER INTERVIEWSPerspectives from 15 global health leaders on
GHIT's catalytic role and Japan's transformational
contributions to global health R&D

GHIT Fund 5th Anniversary Film

FUNDING

Dr. Naoko YamamotoSenior Assistant Minister for Global Health,
Ministry of Health, Labour and Welfare
Dr. Hannah KettlerSenior Program Officer, Life Science Partnerships
Global Health Program, Office of the President
Bill & Melinda Gates Foundation
Prof. Stephen CaddickDirector, Innovations Division,
Wellcome Trust

DISCOVERY

Dr. David ReddyCEO
Medicine for Malaria Venture (MMV)
Mr. George NakayamaRepresentative Director, Chairman and CEO
Daiichi Sankyo Company, Limited
Prof. Kiyoshi KitaProfessor Emeritus, The University of Tokyo
Professor and Dean, Nagasaki University School of Tropical Medicine and Global Health

DEVELOPMENT

Mr. Christophe WeberRepresentative Director, President and CEO
Takeda Pharmaceutical Company Limited
Mr. Yoshihiko HatanakaRepresentative Director, President and CEO
Astellas Pharma Inc.
Dr. Nathalie Strub WourgaftMedical Director
Drugs for Neglected Diseases initiative (DNDi)

ACCESS

Dr. Jayasree K. IyerExecutive Director
Access to Medicine Foundation
Mr. Tetsuo KondoDirector
UNDP Representation Office in Tokyo
Dr. Aya YajimaTechnical Officer
Malaria, other Vectorborne and Parasitic Diseases Unit
Division of Communicable Diseases
World Health Organization Western Pacific Regional Office

POLICY

Dr. Mark DybulFormer Executive Director
The Global Fund to Fight AIDS,
Tuberculosis and Malaria
Dr. Seth BerkleyCEO
Gavi, the Vaccine Alliance
Hon. Prof. Keizo TakemiMember of the House of Councillors of Japan
Chairman, Special Committee on Global Health Strategy
of the Liberal Democratic Party's Policy

SPONSOR INTERVIEWSOur shared vision drives creative partnerships for global health innovation

All Nippon Airways
Yahoo! JAPAN
salesforce.com Co.,Ltd.
MORRISON FOERSTER
Mori Building Co., Ltd.

STAFF STORYDiverse paths lead to global health R&D

Coming Fall 2017